FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4247443318> ?p ?o ?g. }

• W4247443318 endingPage "S70" @default.
• W4247443318 startingPage "S70" @default.
• W4247443318 abstract "ObjectiveTo address patient safety and a source of major obstetrical morbidity, we initiated a comprehensive maternal hemorrhage protocol (HP). The objective of this study was to determine if the HP reduced the severity of OB hemorrhage, the number patients requiring transfusion or the number of units transfused.Study DesingThe key elements of the HP are: admission risk assessment, measurement of blood loss, early uterotonics use, early obstetrician and anesthesiologist presence, and activation of key ancillary hospital personnel. The severity of hemorrhage was based on a 3 stage system: Stage 1=bleeding greater than expected; Stage 2=bleeding not responding to conservative treatment; Stage 3=continued bleeding with actual or expected blood loss to exceed 1500 cc. At Stage 3, fixed ratios of blood products were immediately released (RBC, FFP, Cryo, Plts). Patients activated to each stage were prospectively collected 4 months prior to, and in three 4-month time periods post-HP. The total number of patients receiving blood products and the number of units transfused was compared during the 12-month time period prior to, and after, the HP was initiated. Data was analyzed by T-test and ANOVA.ResultsDuring the study period there were 5813 deliveries. The maternal hemorrhage rate (Stage 1-3) was 4.9%. Relative to pre-HP, fewer patients required Stage 2 intervention post-HP (53%→18%, P=0.02) and more patients were succesfully treated at Stage 1 (35%→82%, p=0.02). There was a trend towards a reduction of patients requiring Stage 3 intervention post-HP (p=0.08). Although the number of patients reaching Stage 3 was not significantly lower, the units of blood products transfused in the 12 months pre-HP was significantly higher than the 12 month Post-HP (16.7→ 6.3 units/month, p<0.01).ConclusionsEstablishing a comprehensive HP produced significant improvement in the severity of maternal hemorrhage and a significant reduction in blood product utilization. Widespread implementation of similar protocols should significantly improve patient safety and utilization of scarce resources. ObjectiveTo address patient safety and a source of major obstetrical morbidity, we initiated a comprehensive maternal hemorrhage protocol (HP). The objective of this study was to determine if the HP reduced the severity of OB hemorrhage, the number patients requiring transfusion or the number of units transfused. To address patient safety and a source of major obstetrical morbidity, we initiated a comprehensive maternal hemorrhage protocol (HP). The objective of this study was to determine if the HP reduced the severity of OB hemorrhage, the number patients requiring transfusion or the number of units transfused. Study DesingThe key elements of the HP are: admission risk assessment, measurement of blood loss, early uterotonics use, early obstetrician and anesthesiologist presence, and activation of key ancillary hospital personnel. The severity of hemorrhage was based on a 3 stage system: Stage 1=bleeding greater than expected; Stage 2=bleeding not responding to conservative treatment; Stage 3=continued bleeding with actual or expected blood loss to exceed 1500 cc. At Stage 3, fixed ratios of blood products were immediately released (RBC, FFP, Cryo, Plts). Patients activated to each stage were prospectively collected 4 months prior to, and in three 4-month time periods post-HP. The total number of patients receiving blood products and the number of units transfused was compared during the 12-month time period prior to, and after, the HP was initiated. Data was analyzed by T-test and ANOVA. The key elements of the HP are: admission risk assessment, measurement of blood loss, early uterotonics use, early obstetrician and anesthesiologist presence, and activation of key ancillary hospital personnel. The severity of hemorrhage was based on a 3 stage system: Stage 1=bleeding greater than expected; Stage 2=bleeding not responding to conservative treatment; Stage 3=continued bleeding with actual or expected blood loss to exceed 1500 cc. At Stage 3, fixed ratios of blood products were immediately released (RBC, FFP, Cryo, Plts). Patients activated to each stage were prospectively collected 4 months prior to, and in three 4-month time periods post-HP. The total number of patients receiving blood products and the number of units transfused was compared during the 12-month time period prior to, and after, the HP was initiated. Data was analyzed by T-test and ANOVA. ResultsDuring the study period there were 5813 deliveries. The maternal hemorrhage rate (Stage 1-3) was 4.9%. Relative to pre-HP, fewer patients required Stage 2 intervention post-HP (53%→18%, P=0.02) and more patients were succesfully treated at Stage 1 (35%→82%, p=0.02). There was a trend towards a reduction of patients requiring Stage 3 intervention post-HP (p=0.08). Although the number of patients reaching Stage 3 was not significantly lower, the units of blood products transfused in the 12 months pre-HP was significantly higher than the 12 month Post-HP (16.7→ 6.3 units/month, p<0.01). During the study period there were 5813 deliveries. The maternal hemorrhage rate (Stage 1-3) was 4.9%. Relative to pre-HP, fewer patients required Stage 2 intervention post-HP (53%→18%, P=0.02) and more patients were succesfully treated at Stage 1 (35%→82%, p=0.02). There was a trend towards a reduction of patients requiring Stage 3 intervention post-HP (p=0.08). Although the number of patients reaching Stage 3 was not significantly lower, the units of blood products transfused in the 12 months pre-HP was significantly higher than the 12 month Post-HP (16.7→ 6.3 units/month, p<0.01). ConclusionsEstablishing a comprehensive HP produced significant improvement in the severity of maternal hemorrhage and a significant reduction in blood product utilization. Widespread implementation of similar protocols should significantly improve patient safety and utilization of scarce resources. Establishing a comprehensive HP produced significant improvement in the severity of maternal hemorrhage and a significant reduction in blood product utilization. Widespread implementation of similar protocols should significantly improve patient safety and utilization of scarce resources." @default.
• W4247443318 created "2022-05-12" @default.
• W4247443318 creator A5008135374 @default.
• W4247443318 creator A5031076332 @default.
• W4247443318 creator A5049870222 @default.
• W4247443318 creator A5061345122 @default.
• W4247443318 creator A5073928517 @default.
• W4247443318 date "2011-01-01" @default.
• W4247443318 modified "2023-10-14" @default.
• W4247443318 title "142: Comprehensive maternal hemorrhage protocols improve patient safety and reduce utilization of blood products" @default.
• W4247443318 doi "https://doi.org/10.1016/j.ajog.2010.10.158" @default.
• W4247443318 hasPublicationYear "2011" @default.
• W4247443318 type Work @default.
• W4247443318 citedByCount "0" @default.
• W4247443318 crossrefType "journal-article" @default.
• W4247443318 hasAuthorship W4247443318A5008135374 @default.
• W4247443318 hasAuthorship W4247443318A5031076332 @default.
• W4247443318 hasAuthorship W4247443318A5049870222 @default.
• W4247443318 hasAuthorship W4247443318A5061345122 @default.
• W4247443318 hasAuthorship W4247443318A5073928517 @default.
• W4247443318 hasConcept C131872663 @default.
• W4247443318 hasConcept C141071460 @default.
• W4247443318 hasConcept C146357865 @default.
• W4247443318 hasConcept C151730666 @default.
• W4247443318 hasConcept C194828623 @default.
• W4247443318 hasConcept C2780014101 @default.
• W4247443318 hasConcept C2991743468 @default.
• W4247443318 hasConcept C42219234 @default.
• W4247443318 hasConcept C71924100 @default.
• W4247443318 hasConcept C86803240 @default.
• W4247443318 hasConceptScore W4247443318C131872663 @default.
• W4247443318 hasConceptScore W4247443318C141071460 @default.
• W4247443318 hasConceptScore W4247443318C146357865 @default.
• W4247443318 hasConceptScore W4247443318C151730666 @default.
• W4247443318 hasConceptScore W4247443318C194828623 @default.
• W4247443318 hasConceptScore W4247443318C2780014101 @default.
• W4247443318 hasConceptScore W4247443318C2991743468 @default.
• W4247443318 hasConceptScore W4247443318C42219234 @default.
• W4247443318 hasConceptScore W4247443318C71924100 @default.
• W4247443318 hasConceptScore W4247443318C86803240 @default.
• W4247443318 hasIssue "1" @default.
• W4247443318 hasLocation W42474433181 @default.
• W4247443318 hasOpenAccess W4247443318 @default.
• W4247443318 hasPrimaryLocation W42474433181 @default.
• W4247443318 hasRelatedWork W2079836057 @default.
• W4247443318 hasRelatedWork W2355125406 @default.
• W4247443318 hasRelatedWork W2358689698 @default.
• W4247443318 hasRelatedWork W2366515927 @default.
• W4247443318 hasRelatedWork W2372098723 @default.
• W4247443318 hasRelatedWork W2373562280 @default.
• W4247443318 hasRelatedWork W2375173177 @default.
• W4247443318 hasRelatedWork W2380479735 @default.
• W4247443318 hasRelatedWork W2390961722 @default.
• W4247443318 hasRelatedWork W2739444387 @default.
• W4247443318 hasVolume "204" @default.
• W4247443318 isParatext "false" @default.
• W4247443318 isRetracted "false" @default.
• W4247443318 workType "article" @default.